Senex Biotechnology. Inc.
Preventing Adaptive Drug Resistance and Cancer Metastasis
5 employees · est. 2002
Senex Biotechnology. Inc. is the older company (2020 vs 2002); Deverra Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Deverra Therapeutics | Senex Biotechnology. Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2002 older |
| Headquarters | ||
| Headquarters | Seattle, United States | Not tracked yet |
| Employees | ||
| Employees | 14 larger | 5 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health and Wellness, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Grant | Debt Financing |
| Total Funding | ||
| Total Funding | $3.58M | $600.00K |
| Funding Rounds | ||
| Funding Rounds | 2 | 2 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cell Therapies, Clinical Stage, Allogeneic Cellular Immunotherapies, Stem Cell Expansion, Directed Differentiation Platform, Cancer Treatment, Infectious Diseases Treatment, Proprietary Technology, Clinical Trials, Immunotherapy, Fred Hutchinson Cancer Research Center, Immune Cell Therapy, Therapeutic Development, Patient-centric Treatment | Senex Biotechnology, Cancer Treatment, Therapeutic Agents, Transcriptional Reprogramming, CDK8/19 Mediator Kinase, Prostate Cancer, Breast Cancer, Clinical Stage Company, Viral Diseases, Age-related Diseases, Drug Resistance, Metastasis, Small-molecule Inhibitors, Oncology Research, Biopharmaceutical Company |
| Website | ||
| Website | deverratx.com | senexbio.com |
About Deverra Therapeutics
Deverra Therapeutics is a biotechnology startup founded in 2019 with a primary focus on developing allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company holds an exclusive license to a proprietary stem cell expansion a...
About Senex Biotechnology. Inc.
Senex Biotechnology, Inc. is a clinical stage company dedicated to preventing transcriptional reprogramming, a process through which cancer cells modify gene expression to adapt to challenging conditions, leading to drug resistance and metastasis. The company's lead program focuses on targeting CDK8...
We will tell you when either one moves
BounceWatch watches Deverra Therapeutics and Senex Biotechnology. Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Deverra Therapeutics and Senex Biotechnology. I... — by email.
Frequently Asked Questions
Compare Deverra Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Deverra Therapeutics on 12 Sep 2024, and Senex Biotechnology. Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
